首页|白细胞介素-2、白细胞介素-4、癌胚抗原、糖类抗原19-9联合检测对结直肠癌的诊断价值及对疗效的预测价值

白细胞介素-2、白细胞介素-4、癌胚抗原、糖类抗原19-9联合检测对结直肠癌的诊断价值及对疗效的预测价值

扫码查看
目的 探讨白细胞介素-2(IL-2)、白细胞介素-4(IL-4)、癌胚抗原(CEA)、糖类抗原19-9(CA19-9)联合检测对结直肠癌的诊断价值及对疗效的预测价值.方法 选取136例结直肠癌患者和50例健康体检者,比较两组受试者以及不同疗效结直肠癌患者血清IL-2、IL-4、CA19-9、CEA水平.绘制受试者工作特征(ROC)曲线,计算曲线下面积(AUC),评估IL-2、IL-4、CEA、CA19-9单独及联合检测对结直肠癌的诊断价值及对疗效的预测价值.结果 结直肠癌患者血清IL-2水平明显低于健康者,IL-4、CEA、CA19-9水平均明显高于健康者,差异均有统计学意义(P<0.01).ROC曲线显示,IL-2、IL-4、CEA、CA19-9联合检测诊断结直肠癌的AUC为0.910(95%CI:0.853~0.966),高于各指标单独检测,此时的灵敏度为0.971,特异度为0.820.136例结直肠癌患者治疗后,有效95例,无效41例,分别作为有效组和无效组,无效组患者血清IL-2水平明显低于有效组,IL-4、CEA、CA19-9水平均明显高于有效组,差异均有统计学意义(P<0.01).ROC曲线显示,血清IL-2、IL-4、CEA、CA19-9联合检测预测结直肠癌患者疗效的AUC为0.956(95%CI:0.925~0.987),高于各指标单独检测,此时的灵敏度为0.902,特异度为0.916.结论 血清IL-2、IL-4、CEA、CA19-9联合检测对结直肠癌的诊断价值及对疗效的预测价值均较高,临床可通过检测上述指标来为结直肠癌的诊疗提供参考.
Diagnostic value of interleukin-2,interleukin-4,carcinoembryonic antigen,and carbohydrate antigen 19-9 combined detection in colorectal cancer and its therapeutic effect predictive value
Objective To explore the diagnostic value of interleukin-2(IL-2),interleukin-4(IL-4),carcinoembryonic antigen(CEA),and carbohydrate antigen 19-9(CA19-9)combined detection in colorectal cancer and its therapeutic ef-fect predictive value.Method A total of 136 colorectal cancer patients and 50 healthy individuals were selected,and the serum levels of IL-2,IL-4,CA19-9,and CEA were compared between the two groups of subjects and patients with colorectal cancer with different prognosis.The receiver operating characteristic(ROC)curve was drawn,and the area un-der the curve(AUC)was calculated,the diagnostic value of IL-2,IL-4,CEA,and CA19-9 single and combined detection for colorectal cancer and its therapeutic effect predictive value were evaluated.Result The serum IL-2 level in colorec-tal cancer patients was significantly lower than that in healthy individuals,and the levels of IL-4,CEA,and CA19-9 were significantly higher than those in healthy individuals,and the differences were statistically significant(P<0.01).The ROC curve showed that the AUC of IL-2,IL-4,CEA,and CA19-9 combined detection in diagnosing colorectal cancer was 0.910(95%CI:0.853-0.966),which was higher than the individual detection of each indicator,the sensitivity was 0.971 and the specificity was 0.820.After treatment,95 cases effective and 41 cases ineffective in 136 patients with colorectal cancer,respectively,which were divided into effective group and ineffective group.The serum IL-2 level in the ineffec-tive group was significantly lower than that in the effective group,while the levels of IL-4,CEA,and CA19-9 were signif-icantly higher than those in the effective group,and the differences were statistically significant(P<0.01).The ROC curve showed that the AUC of serum IL-2,IL-4,CEA,and CA19-9 combined detection in predicting efficacy of colorectal can-cer patients was 0.956(95%CI:0.925-0.987),which was higher than the single detection of each indicator,the sensitivity was 0.902,the specificity was 0.916.Conclusion The serum IL-2,IL-4,CEA,and CA19-9 combined detection has a high diagnostic value and therapeutic effect predictive value for colorectal cancer.Clinically,the detection of these indica-tors can provide reference for the diagnosis and treatment of colorectal cancer.

colorectal cancerinterleukin-2interleukin-4carcinoembryonic antigencarbohydrate antigen 19-9di-agnosis

叶施雨、陈秋丹、赵梦丹、陈佳栋

展开 >

复旦大学附属华山医院静安分院/上海市静安区中心医院检验科,上海 200040

复旦大学附属华山医院静安分院/上海市静安区中心医院普外科,上海 200040

结直肠癌 白细胞介素-2 白细胞介素-4 癌胚抗原 糖类抗原19-9 诊断

上海市卫生健康委员会科研项目

202140240

2024

癌症进展
中国医学科学院,北京协和医学院

癌症进展

影响因子:1.004
ISSN:1672-1535
年,卷(期):2024.22(12)